Related Experiment Video
Updated: Jan 25, 2026

Mouse In Vivo Placental Targeted CRISPR Manipulation
Published on: April 14, 2023
Placental Origins of Preeclampsia: Potential Therapeutic Targets
Jian-Li Wu1, Jing Jia1, Meng-Zhou He1
1Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 4300030, China.
Insights
Preeclampsia (PE) is a major obstetric complication with no current treatments. This review explores potential therapeutic targets for PE, focusing on placental dysfunction and emerging research technologies.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
- Maternal-Fetal Medicine
Background:
- Preeclampsia (PE) is a significant global cause of maternal and perinatal mortality.
- Current clinical practices lack effective treatments to mitigate PE incidence or severity.
- Genetic predispositions and placental dysfunction are key hypotheses for PE etiology.
Purpose of the Study:
- To review potential therapeutic targets for preeclampsia based on placental dysfunction.
- To discuss research models investigating PE pathophysiology.
- To introduce advanced technologies in current placental research.
Main Methods:
- Literature review of basic research on preeclampsia.
- Analysis of identified therapeutic targets in PE models.
- Discussion of evolving placental research technologies.
Main Results:
- Several potential therapeutic targets have been identified through basic research on placental dysfunction.
- Key areas for therapeutic intervention include uteroplacental blood flow, oxidative stress, vasoactive factors, and inflammation/immune response.
- Advancements in placental research technologies are facilitating deeper understanding.
Conclusions:
- Targeting placental dysfunction offers promising avenues for novel preeclampsia therapies.
- Continued research into specific pathways and technological advancements is crucial for developing effective treatments.
- Understanding the complex interplay of factors in PE is essential for improving maternal and perinatal outcomes.
Abstract:
Preeclampsia (PE) remains a leading cause of maternal and perinatal morbidity and mortality in obstetrics worldwide. No effective treatments to reduce its incidence and severity in clinical practice are currently available. A variety of hypotheses have been generated aiming to explain the origins of PE, notably being the genetic predispositions and placental dysfunction. As regard to placental dysfunction, much progress has been made in basic research and several potential therapeutic targets have been identified. This review will discuss in detail the potential therapeutic targets in PE models including uteroplacental blood flow, oxidative stress, vasoactive factors and inflammation/immune response, and introduce the evolving technologies for placental research nowadays.
More Related Videos
Related Concept Videos
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair...
Therapeutic Index
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Cancers Originate from Somatic Mutations in a Single Cell
Standard Electrode Potentials
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

